Call for applications: Editor-in-Chief Neuro-Oncology Advances
The European Association of Neuro-Oncology (EANO) and the Society for Neuro-Oncology (SNO) are accepting applications for the Editor-in-Chief of Neuro-Oncology Advances.
The ideal candidate will have a strong background in neuro-oncology, an outstanding track record in neuro-oncology and the ability to lead a collaborative and inclusive editorial team with experience in an executive editorial role.
Application deadline: May 31, 2025
About the journal Neuro-Oncology Advances
Neuro-Oncology Advances (NOA) was launched in 2019 as the first open-access journal published by OUP in partnership with the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO). Its aim is to ensure that research and discoveries in the field are accessible to a broader readership and retained within the wider neuro-oncology community.
NOA is an inter-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neuroradiologists, and researchers together with educators. In 2024, the Impact Factor of the journal increased to 3.7.
About the Editor-in-Chief Position
The ideal candidate will have an outstanding track record of research in neuro-oncology, with a strong publication record and significant contributions to the review and editing of published material within the Neuro-Oncology family of journals. They should possess an excellent international network among researchers and leaders in the field, along with the ability to lead a collaborative and inclusive editorial team. Experience in an executive editorial role is essential. The position is for a seven-year term.
For the full description of the position and additional information on how to apply, please click 
here.
Call for Application EANO Committees 2025
EANO is THE Association for Neuro-Oncology in Europe and has launched several committees where your support and input as experts in the field of Neuro-Oncology are highly appreciated.
EANO is looking for active new members for the Nurses and Allied Healthcare Professionals Committee (NAC), as well as for the newly formed Brain Tumour Advocacy Committee (BTAC) who will start their engagement after the General Assembly in Prague 2025. The Committees are composed of representatives from different subspecialties with a balance regarding European countries and gender. The duration of the position is two years, with the possibility of one re-election, depending on the input of the member.
Applications for the Executive Board at the same time are not possible; however, applications for another EANO Committee are possible by indicating primary and secondary choices, also former Executive Board members are very welcome to apply!
click here for application details Nurses and Allied Healthcare Professionals Committee (NAC)
click here for application details Brain Tumour Advocacy Committee (BTAC)
The EANO Executive Board as well as the Chairs of the Committees are looking forward to receiving your application!
Application deadlines:
NEW DEADLINE: April 14, 2025 for Brain Tumour Advocacy Committee
May 31, 2025 for Nurses and Allied Health Care Professionals Committee
Abstracts
Abstract submission for EANO 2025 is OPEN!
Submission deadline: Tuesday, April 30, 2025 at 23:59 hrs CEST.
For more information on the abstract submission, click here
Why Become an EANO Member?
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
Today, EANO has over 700 members from more than 70 countries. EANO stimulates (inter)national cooperation together with our major partner societies, the Society of Neuro-Oncology in the US (SNO) and the Asian Society of Neuro-Oncology (ASNO); together, EANO, SNO and ASNO are charter societies of the World Federation of Neuro-Oncology Societies (WFNOS).
The EANO Youngster Initiative provides a platform for exchange, networking and career support for young clinicians and scientists.
EANO provides multiple services to its members. We organise scientific and educational webinars and meetings with 'state of the art' lectures covering the broad spectrum of all disciplines in Neuro-Oncology, including our flagship annual EANO Meeting and the quadrennial WFNOS Meeting.
Further, EANO offers exclusively to its members free access to Neuro Oncology, Neuro Oncology Practice and the Neuro Oncology Advances Journals.
EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care for brain tumour patients across Europe. The EANO Youngster Initiative is a highly active platform for exchange, networking and career support for young clinicians and scientists. We also offer high level post-graduate education through the EANO School of Neuro-Oncology launched in 2022 and strongly support increasing diversity in the Neuro-Oncology community.
Kind Regards
Michael Platten
EANO President (2024-2026)
